Autoantibodies and immunogenetics in 30 patients with systemic sclerosis and their families

J Rheumatol. 1987 Aug;14(4):760-5.

Abstract

Clinical and serological evidence of connective tissue disease was found in a high proportion of 132 family members of 30 patients with systemic sclerosis. In 20 probands with the milder CREST form of the disease, 10 had HLA-DR5 and 12 had null alleles at the C4 loci. None of 11 probands with more severe systemic sclerosis had HLA-DR5; all 11 had null alleles at the C4 loci. All but two of the probands had either HLA-DR5 or a C4 null allele, and this was also the case for the majority of the relatives with autoantibodies. Genetic markers of the major histocompatibility complex, including HLA-DR5 and C4 null alleles, appear to be closely associated with markers of disease in these probands and their families.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Antinuclear / analysis
  • Autoantibodies / analysis*
  • Autoantibodies / genetics
  • Complement C4 / analysis
  • Complement C4a
  • Complement C4b
  • Female
  • HLA Antigens / analysis*
  • HLA-A Antigens
  • HLA-C Antigens
  • HLA-D Antigens / analysis
  • HLA-DR Antigens / analysis
  • HLA-DR5 Antigen
  • Haplotypes
  • Humans
  • Major Histocompatibility Complex*
  • Male
  • Pedigree
  • Scleroderma, Systemic / genetics
  • Scleroderma, Systemic / immunology*

Substances

  • Antibodies, Antinuclear
  • Autoantibodies
  • Complement C4
  • HLA Antigens
  • HLA-A Antigens
  • HLA-C Antigens
  • HLA-D Antigens
  • HLA-DR Antigens
  • HLA-DR5 Antigen
  • Complement C4a
  • Complement C4b